Almac is a global CDMO providing integrated Chemistry, Manufacturing and Controls (CMC) solutions to support drug development from concept through to commercialisation. By combining drug substance development, analytical services, drug product development and commercial manufacturing within a single organisation, we help clients simplify outsourcing, reduce risk and accelerate timelines. With expertise in small molecules, peptides and enabling technologies such as biocatalysis, flow chemistry and physical sciences, Almac delivers scalable and efficient development strategies.
Our integrated chemical and pharmaceutical development teams work collaboratively to optimise product performance and support seamless progression through development. From First-in-Human studies and late-phase clinical programmes to registration batches and commercial manufacture, we offer innovative capabilities for potent and non-potent oral dose products. A single-partner approach provides scientific continuity, aligned quality systems and streamlined project oversight, helping clients navigate development challenges and accelerate the path from molecule to market.